help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hsu, D.
Right arrow Articles by Olefsky, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hsu, D.
Right arrow Articles by Olefsky, J. M.

Endocrinology, Vol 134, 744-750, Copyright © 1994 by Endocrine Society


ARTICLES

NPXY motif in the insulin-like growth factor-I receptor is required for efficient ligand-mediated receptor internalization and biological signaling

D Hsu, PE Knudson, A Zapf, GC Rolband and JM Olefsky
Department of Medicine, University of California-San Diego, La Jolla 92093.

The NPXY motif that was identified in the low density lipoprotein receptor serves as an internalization signal, and subsequent studies have indicated that the NPXY sequence is also an important recognition element for internalization of both insulin and transferrin receptors. The insulin-like growth factor (IGF-I) receptor contains an NPXY sequence (residues 947-950) in the immediate submembranous domain, and we sought to determine whether these residues play a role in facilitating ligand-mediated internalization of the IGF-I receptor. To study this, we have constructed stable cell lines expressing NPXY deletion mutant receptors (CHONPXY) or wild-type receptors (CHOWT). Ligand internalization studies showed that CHONPXY cells internalized [125I]IGF-I with a 40% defect (P < 0.005) compared to the CHOWT cells. Ligand-mediated receptor internalization and down-regulation were decreased by 90% in CHONPXY compared to CHOWT cells. The kinase activity of the mutant receptors was also defective as a result of removal of the NPXY motif. This is in contrast to the insulin receptor, in which deletion of the NPXY motif or deletions of even larger portions of amino acids in proximity to the NPXY motif do not affect the kinase activity of the receptor. Finally, the ability of the mutant receptors to mediate biological signaling is also defective, as measured by the thymidine incorporation assay.


This article has been cited by other articles:


Home page
Mol. Biol. CellHome page
M. Donoso, J. Cancino, J. Lee, P. van Kerkhof, C. Retamal, G. Bu, A. Gonzalez, A. Caceres, and M.-P. Marzolo
Polarized Traffic of LRP1 Involves AP1B and SNX17 Operating on Y-dependent Sorting Motifs in Different Pathways
Mol. Biol. Cell, January 1, 2009; 20(1): 481 - 497.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. S. Pandey, E. N. Harris, J. A. Weigel, and P. H. Weigel
The Cytoplasmic Domain of the Hyaluronan Receptor for Endocytosis (HARE) Contains Multiple Endocytic Motifs Targeting Coated Pit-mediated Internalization
J. Biol. Chem., August 1, 2008; 283(31): 21453 - 21461.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Y. Chen, X. Wang, J. Ben, S. Yue, H. Bai, X. Guan, X. Bai, L. Jiang, Y. Ji, L. Fan, et al.
The Di-Leucine Motif Contributes to Class A Scavenger Receptor-Mediated Internalization of Acetylated Lipoproteins
Arterioscler Thromb Vasc Biol, June 1, 2006; 26(6): 1317 - 1322.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. D. Dahlen, V. C. Broudy, and J. G. Drachman
Internalization of the thrombopoietin receptor is regulated by 2 cytoplasmic motifs
Blood, July 1, 2003; 102(1): 102 - 108.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Sachdev, S.-L. Li, J. S. Hartell, Y. Fujita-Yamaguchi, J. S. Miller, and D. Yee
A Chimeric Humanized Single-Chain Antibody against the Type I Insulin-like Growth Factor (IGF) Receptor Renders Breast Cancer Cells Refractory to the Mitogenic Effects of IGF-I
Cancer Res., February 1, 2003; 63(3): 627 - 635.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. M. Najjar, C. V. Choice, P. Soni, C. M. Whitman, and M. N. Poy
Effect of pp120 on Receptor-mediated Insulin Endocytosis Is Regulated by the Juxtamembrane Domain of the Insulin Receptor
J. Biol. Chem., May 22, 1998; 273(21): 12923 - 12928.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. C. Chow, G. Condorelli, and R. J. Smith
Insulin-like Growth Factor-I Receptor Internalization Regulates Signaling via the Shc/Mitogen-activated Protein Kinase Pathway, but Not the Insulin Receptor Substrate-1 Pathway
J. Biol. Chem., February 20, 1998; 273(8): 4672 - 4680.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. A. Kenner, E. Anyanwu, J. M. Olefsky, and J. Kusari
Protein-tyrosine Phosphatase 1B Is a Negative Regulator of Insulin- and Insulin-like Growth Factor-I-stimulated Signaling
J. Biol. Chem., August 16, 1996; 271(33): 19810 - 19816.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. L. Seely, D. R. Reichart, P. A. Staubs, B. H. Jhun, D. Hsu, H. Maegawa, K. L. Milarski, A. R. Saltiel, and J. M. Olefsky
Localization of the Insulin-like Growth Factor I Receptor Binding Sites for the SH2 Domain Proteins p85, Syp, and GTPase Activating Protein
J. Biol. Chem., August 11, 1995; 270(32): 19151 - 19157.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society